Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
King's College London
King's College London
Suzhou Genhouse Bio Co., Ltd.
Irish Research Radiation Oncology Group
Mahidol University
University of Milan
Wellmarker Bio
West China Hospital
Ottawa Hospital Research Institute
Centre hospitalier de l'Université de Montréal (CHUM)
Kuwait Cancer Control Center
Sixth Affiliated Hospital, Sun Yat-sen University
Poitiers University Hospital
University Hospital, Ghent
University College, London
Sunnybrook Health Sciences Centre
Nanfang Hospital, Southern Medical University
National Cancer Institute, Naples
The Netherlands Cancer Institute
Rigshospitalet, Denmark
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Centre Georges Francois Leclerc
AronPharma Sp. z o. o.
Centre Leon Berard
Instituto Nacional de Cancer, Brazil
Guy's and St Thomas' NHS Foundation Trust
Chang Gung Memorial Hospital
Chang Gung Memorial Hospital
Tosk, Inc.
Massachusetts General Hospital
Johann Wolfgang Goethe University Hospital
Kineta Inc.
P-Cure
George Washington University
Southern Tohoku BNCT Research Center
Shanghai Yunying Medical Technology
Universitätsklinikum Hamburg-Eppendorf
Erasmus Medical Center
Rigshospitalet, Denmark
Shanghai Yunying Medical Technology
Universitaire Ziekenhuizen KU Leuven
Federal University of Rio Grande do Sul
Jules Bordet Institute
University of Brawijaya
Rigshospitalet, Denmark
Kaohsiung Medical University Chung-Ho Memorial Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Centre Hospitalier Universitaire, Amiens
Nanobiotix
Chinese University of Hong Kong
Centre Henri Becquerel